Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1908 1
1919 1
1921 1
1923 1
1925 1
1927 2
1928 1
1929 2
1930 2
1931 1
1932 3
1941 1
1942 5
1943 2
1944 1
1946 1
1947 1
1948 3
1949 2
1950 5
1951 3
1952 3
1953 10
1954 8
1955 9
1956 6
1957 18
1958 23
1959 19
1960 21
1961 14
1962 8
1963 3
1964 3
1965 4
1966 1
1967 3
1968 4
1969 8
1970 2
1971 5
1972 4
1973 7
1974 10
1975 3
1976 5
1977 10
1978 6
1979 12
1980 11
1981 21
1982 7
1983 12
1984 20
1985 14
1986 17
1987 16
1988 22
1989 16
1990 21
1991 19
1992 31
1993 33
1994 24
1995 26
1996 29
1997 35
1998 26
1999 20
2000 20
2001 32
2002 31
2003 22
2004 26
2005 26
2006 24
2007 23
2008 28
2009 45
2010 26
2011 40
2012 25
2013 30
2014 31
2015 37
2016 50
2017 45
2018 35
2019 35
2020 32
2021 28
Text availability
Article attribute
Article type
Publication date

Search Results

1,303 results
Results by year
Filters applied: . Clear all
Page 1
RECIST 1.1-Update and clarification: From the RECIST committee.
Schwartz LH, Litière S, de Vries E, Ford R, Gwyther S, Mandrekar S, Shankar L, Bogaerts J, Chen A, Dancey J, Hayes W, Hodi FS, Hoekstra OS, Huang EP, Lin N, Liu Y, Therasse P, Wolchok JD, Seymour L. Schwartz LH, et al. Among authors: ford r. Eur J Cancer. 2016 Jul;62:132-7. doi: 10.1016/j.ejca.2016.03.081. Epub 2016 May 14. Eur J Cancer. 2016. PMID: 27189322 Free PMC article.
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics.
Seymour L, Bogaerts J, Perrone A, Ford R, Schwartz LH, Mandrekar S, Lin NU, Litière S, Dancey J, Chen A, Hodi FS, Therasse P, Hoekstra OS, Shankar LK, Wolchok JD, Ballinger M, Caramella C, de Vries EGE; RECIST working group. Seymour L, et al. Among authors: ford r. Lancet Oncol. 2017 Mar;18(3):e143-e152. doi: 10.1016/S1470-2045(17)30074-8. Epub 2017 Mar 2. Lancet Oncol. 2017. PMID: 28271869 Free PMC article. Review.
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J. Eisenhauer EA, et al. Among authors: ford r. Eur J Cancer. 2009 Jan;45(2):228-47. doi: 10.1016/j.ejca.2008.10.026. Eur J Cancer. 2009. PMID: 19097774
Treatment of nonalcoholic fatty liver disease: role of AMPK.
Smith BK, Marcinko K, Desjardins EM, Lally JS, Ford RJ, Steinberg GR. Smith BK, et al. Among authors: ford rj. Am J Physiol Endocrinol Metab. 2016 Oct 1;311(4):E730-E740. doi: 10.1152/ajpendo.00225.2016. Epub 2016 Aug 30. Am J Physiol Endocrinol Metab. 2016. PMID: 27577854 Free article. Review.
AMPK as a Therapeutic Target for Treating Metabolic Diseases.
Day EA, Ford RJ, Steinberg GR. Day EA, et al. Among authors: ford rj. Trends Endocrinol Metab. 2017 Aug;28(8):545-560. doi: 10.1016/j.tem.2017.05.004. Epub 2017 Jun 21. Trends Endocrinol Metab. 2017. PMID: 28647324 Review.
Structural and functional diversity calls for a new classification of ABC transporters.
Thomas C, Aller SG, Beis K, Carpenter EP, Chang G, Chen L, Dassa E, Dean M, Duong Van Hoa F, Ekiert D, Ford R, Gaudet R, Gong X, Holland IB, Huang Y, Kahne DK, Kato H, Koronakis V, Koth CM, Lee Y, Lewinson O, Lill R, Martinoia E, Murakami S, Pinkett HW, Poolman B, Rosenbaum D, Sarkadi B, Schmitt L, Schneider E, Shi Y, Shyng SL, Slotboom DJ, Tajkhorshid E, Tieleman DP, Ueda K, Váradi A, Wen PC, Yan N, Zhang P, Zheng H, Zimmer J, Tampé R. Thomas C, et al. Among authors: ford r. FEBS Lett. 2020 Dec;594(23):3767-3775. doi: 10.1002/1873-3468.13935. Epub 2020 Oct 26. FEBS Lett. 2020. PMID: 32978974 Review.
RECIST 1.1 - Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group.
Schwartz LH, Seymour L, Litière S, Ford R, Gwyther S, Mandrekar S, Shankar L, Bogaerts J, Chen A, Dancey J, Hayes W, Hodi FS, Hoekstra OS, Huang EP, Lin N, Liu Y, Therasse P, Wolchok JD, de Vries E. Schwartz LH, et al. Among authors: ford r. Eur J Cancer. 2016 Jul;62:138-45. doi: 10.1016/j.ejca.2016.03.082. Epub 2016 May 26. Eur J Cancer. 2016. PMID: 27237360 Free PMC article. Review.
Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma.
Lally JSV, Ghoshal S, DePeralta DK, Moaven O, Wei L, Masia R, Erstad DJ, Fujiwara N, Leong V, Houde VP, Anagnostopoulos AE, Wang A, Broadfield LA, Ford RJ, Foster RA, Bates J, Sun H, Wang T, Liu H, Ray AS, Saha AK, Greenwood J, Bhat S, Harriman G, Miao W, Rocnik JL, Westlin WF, Muti P, Tsakiridis T, Harwood HJ Jr, Kapeller R, Hoshida Y, Tanabe KK, Steinberg GR, Fuchs BC. Lally JSV, et al. Among authors: ford rj. Cell Metab. 2019 Jan 8;29(1):174-182.e5. doi: 10.1016/j.cmet.2018.08.020. Epub 2018 Sep 20. Cell Metab. 2019. PMID: 30244972 Free PMC article.
1,303 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page